Implantable System Risk Assessment and Remote Reactivation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current implantable systems for treating heart arrhythmias, such as cardiac pacemakers, face challenges in predicting effective treatments for atrial tachycardia and require frequent patient visits for follow-up, leading to complexity and reduced patient comfort.

Innovation Solution

An implantable system equipped with a processor, memory unit, and remote data transmission unit that assesses potential patient risks and deactivates treatment functionalities as needed, allowing for remote reactivation by trained medical staff via secure data transmission, reducing the need for frequent patient visits.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If treatment functionalities are deactivated when patient risk is identified, then patient safety is improved, but device functionality and treatment availability deteriorate

Engineering Contradiction:
Improvepatient safetyVSAvoidtreatment functionality
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

A secure communication module acts as an intermediary between the implantable device and external systems. When a treatment functionality is deactivated due to patient risk, the system communicates with external medical staff through encrypted channels to coordinate safe reactivation, thus maintaining both safety and functionality

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The implantable device performs self-assessment of patient risk conditions and automatically deactivates treatment functionalities when risks are detected. This self-service capability allows the device to maintain safety without requiring constant external monitoring, while preserving the ability to reactivate functions when safe

Inventive Principle:
Principle #25Self-service

2Reliability

If frequent follow-up visits are required for reactivation, then patient safety monitoring is improved, but patient comfort and healthcare system efficiency deteriorate

Engineering Contradiction:
Improvesafety monitoringVSAvoidpatient comfort
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The system implements continuous feedback through secure data transmission between the implantable device and external systems. Treatment functionalities are deactivated based on risk assessment feedback, and reactivation occurs automatically or through coordinated communication when safety conditions are met, eliminating the need for frequent physical follow-up visits

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent replaces the mechanical system of in-person follow-up visits with electronic secure communication and remote data transmission. Medical staff can assess patient status and reactivate treatment functionalities through encrypted digital channels, substituting physical presence with electronic monitoring and communication

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If multiple specialized physician visits are required, then treatment precision and safety are improved, but healthcare complexity and resource utilization deteriorate

Engineering Contradiction:
Improvetreatment precisionVSAvoidfollow-up complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The secure communication module provides multi-functional capabilities including risk assessment, treatment deactivation, reactivation coordination, and encrypted data transmission. This single integrated system performs multiple functions that previously required separate specialized physician interventions, reducing overall system complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS11684787B2Implantable system for the diagnostic and/or therapeutic treatment of a human patient or an animal patient
Publication Date: 2023.06.27 BIOTRONIK SE & CO KG
  • US11684787B2 patent drawing
  • US11684787B2 patent drawing
  • US11684787B2 patent drawing

AI summary

An implantable system for the diagnostic and/or therapeutic treatment of a human or animal patient contains a processor, a memory, a treatment unit and a remote data transmission unit. The system is characterized in that the memory includes a computer-readable program which prompts the processor to carry out the following steps when the program is being executed on the processor: a) ascertaining whether a treatment functionality of the treatment unit could jeopardize a patient in whom the system was implanted if a diagnostic and/or therapeutic treatment of the patient corresponding to the treatment functionality were to be carried out; b) deactivating the treatment functionality when a potential risk for the patient was ascertained; c) receiving reactivation data by way of the remote data transmission unit; and d) reactivating the deactivated treatment functionality based on the received reactivation data.